Authors:
COUPRY I
ARMSBY CC
ALPER SL
BRUGNARA C
PARINI A
Citation: I. Coupry et al., CLOTRIMAZOLE AND EFAROXAN INHIBIT RED-CELL GARDOS CHANNEL INDEPENDENTLY OF IMIDAZOLINE I-1 AND I-2 BINDING-SITES, European journal of pharmacology, 295(1), 1996, pp. 109-112
Citation: F. Chaouloff et al., CORTICAL [H-3] KETANSERIN BINDING AND 5-HT(2A) RECEPTOR-MEDIATED BEHAVIORAL-RESPONSES IN OBESE ZUCKER RATS, Pharmacology, biochemistry and behavior, 50(2), 1995, pp. 309-312
Authors:
LANIER B
RADDATZ R
BAKTHAVACHALAM V
COUPRY I
NEUMEYER JL
LANIER SM
Citation: B. Lanier et al., STRUCTURAL AND LIGAND RECOGNITION PROPERTIES OF IMIDAZOLINE BINDING-PROTEINS IN TISSUES OF RAT AND RABBIT, Molecular pharmacology, 48(4), 1995, pp. 703-710
Authors:
TESSON F
LIMONBOULEZ I
URBAN P
PUYPE M
VANDEKERCKHOVE J
COUPRY I
POMPON D
PARINI A
Citation: F. Tesson et al., LOCALIZATION OF I-2-IMIDAZOLINE BINDING-SITES ON MONOAMIME OXIDASES, The Journal of biological chemistry, 270(17), 1995, pp. 9856-9861
Citation: F. Chaouloff et al., EFFECTS OF CHLORISONDAMINE AND RESTRAINT ON CORTICAL [H-3] KETANSERINBINDING, 5-HT2A, RECEPTOR-MEDIATED HEAD SHAKES, AND BEHAVIORS IN MODELS OF ANXIETY, Neuropharmacology, 33(3-4), 1994, pp. 449-456
Citation: F. Chaouloff et al., BEHAVIORAL AND BIOCHEMICAL-EVIDENCE THAT GLUCOCORTICOIDS ARE NOT INVOLVED IN DOI-ELICITED 5-HT(2) RECEPTOR DOWN-REGULATION, European journal of pharmacology, 249(1), 1993, pp. 117-120